These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12505254)

  • 1. Characterization of chromosomal aberrations in a case of glioblastoma multiforme combining cytogenetic and molecular cytogenetic techniques.
    Zuber MA; Krupp W; Holland H; Froster UG
    Cancer Genet Cytogenet; 2002 Oct; 138(2):111-5. PubMed ID: 12505254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas.
    Krupp W; Geiger K; Schober R; Siegert G; Froster UG
    Cancer Genet Cytogenet; 2004 Aug; 153(1):32-8. PubMed ID: 15325091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recurrent 19q11-12 breakpoint suggested by cytogenetic and fluorescence in situ hybridization analysis of three glioblastoma cell lines.
    Magnani I; Chiariello E; Conti AM; Finocchiaro G
    Cancer Genet Cytogenet; 1999 Apr; 110(2):82-6. PubMed ID: 10214354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidden aberrations diagnosed by interphase fluorescence in situ hybridisation and spectral karyotyping in childhood acute lymphoblastic leukaemia.
    Nordgren A
    Leuk Lymphoma; 2003 Dec; 44(12):2039-53. PubMed ID: 14959846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
    Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
    Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
    Hilgenfeld E; Padilla-Nash H; McNeil N; Knutsen T; Montagna C; Tchinda J; Horst J; Ludwig WD; Serve H; Büchner T; Berdel WE; Schröck E; Ried T
    Br J Haematol; 2001 May; 113(2):305-17. PubMed ID: 11380393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral karyotyping study of chromosome abnormalities in human leukemia.
    Zhao L; Hayes K; Khan Z; Glassman A
    Cancer Genet Cytogenet; 2001 Jun; 127(2):143-7. PubMed ID: 11425454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
    Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
    Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
    Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
    Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of recurrent chromosomal rearrangements and the unique relationship between low-level amplification and translocation in glioblastoma.
    Kubota H; Nishizaki T; Harada K; Harada K; Oga A; Ito H; Suzuki M; Sasaki K
    Genes Chromosomes Cancer; 2001 Jun; 31(2):125-33. PubMed ID: 11319800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping.
    Padilla-Nash HM; Nash WG; Padilla GM; Roberson KM; Robertson CN; Macville M; Schröck E; Ried T
    Genes Chromosomes Cancer; 1999 May; 25(1):53-9. PubMed ID: 10221340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cytogenetic analysis of glioblastoma multiforme.
    Mao X; Hamoudi RA
    Cancer Genet Cytogenet; 2000 Oct; 122(2):87-92. PubMed ID: 11106817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
    Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH
    Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting.
    Micci F; Teixeira MR; Heim S
    Cancer Genet Cytogenet; 2001 Nov; 131(1):25-30. PubMed ID: 11734314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme.
    Leone PE; González MB; Elosua C; Gómez-Moreta JA; Lumbreras E; Robledo C; Santos-Briz A; Valero JM; de la Guardia RD; Gutiérrez NC; Hernández JM; García JL
    Ann Surg Oncol; 2012 Jul; 19(7):2367-79. PubMed ID: 22395973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization.
    Vranová V; Necesalová E; Kuglík P; Cejpek P; Pesáková M; Budínská E; Relichová J; Veselská R
    Oncol Rep; 2007 Feb; 17(2):457-64. PubMed ID: 17203188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways.
    Dahlback HS; Brandal P; Meling TR; Gorunova L; Scheie D; Heim S
    Genes Chromosomes Cancer; 2009 Oct; 48(10):908-24. PubMed ID: 19603525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
    Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
    Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of molecular cytogenetic methods for the detection of chromosomal abnormalities.
    Une T; Yokoyama Y; Ninomiya S; Shinozuka M; Maruyama H; Morishima T
    Acta Med Okayama; 2006 Oct; 60(5):279-87. PubMed ID: 17072374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.